All systems operational
For Researchers For Publishers Login Register
Home Publications Saudi Medical Journal
Q2 2024

Effectiveness and safety of rivaroxaban for anticoagulation therapy in COVID-19

Xiangbo Shen · Eryue Qiu · Zhao Liu · Xiaopeng Zhu · Yiqian Zeng
10.15537/smj.2024.45.4.20230728 386 Views 1 Citations
1
Citations
386
Views
Abstract not available for this publication.
Cite this Article (APA)
Xiangbo, S., Eryue, Q., Zhao, L., Xiaopeng, Z., Yiqian, Z. (2024). Effectiveness and safety of rivaroxaban for anticoagulation therapy in COVID-19. Saudi Medical Journal. https://doi.org/10.15537/smj.2024.45.4.20230728
Related Papers
Overview of hypertension in Saudi Arabia
Sulaiman A. Alshammari; Abdullah S. Alshammari; Hotoon S. Alshammari; Shaik S. A · 2023
45
cites
390
Bilateral external oblique intercostal plane block (EOIPB) in patients undergoing laparoscopic chole…
Muhammet Korkusuz; Betul Basaran; Tayfun Et; Aysegul Bilge; Rafet Yarimoglu; Has · 2023
33
cites
389
War and Health Crisis in Gaza
Fahdah Alokaily · 2024
25
cites
392
Validity of the International Diabetes Federation risk stratification score of Ramadan fasting in in…
Eman M. Alfadhli; Taif S. Alharbi; Abrar M. Alrotoie; Asia A. Aljohani; Amal S. · 2024
20
cites
394
Access
View Full Text via DOI
Published in
ISSN 0379-5284
Quartile Q2
AMS Score 88
Field Medicine & Health Sciences
Publisher Ministry of Defense Health Services
Country 🇸🇦 Saudi Arabia
View Journal Profile →
Authors
Publication Details
Year 2024
Language English
Added 02 Aug 2026